India's Shilpa Medicare rises as biologics arm gets EU certification
05/05/2025 08:18
** Shilpa Medicare SHME.NS up 4.4% to 658.4 rupees ** Co's biologics arm Shilpa Biologics' site in Karnataka gets European Good Manufacturing Practice (GMP) certification for manufacturing of test batches ** Stock set to snap five straight sessions of losses ** SHME trims YTD losses to ~19% (Reporting by Anuran Sadhu in Bengaluru) ((Anuran.Sadhu@thomsonreuters.com; +91 8697274436;))
Recent news on Shilpa Medicare
See all newsBrief: Shilpa Medicare Q2 Consol Net Profit INR 791.8 Million
Brief: Shilpa Medicare Says USFDA Conducts Surveillance Inspection At Shilpa Medicare Unit
Brief: Shilpa Medicare Receives Final SEC Approval For Oeris Marketing Authorization
India's Shilpa Medicare gains on approval for OERIS
Brief: Shilpa Medicare Initiates Voluntary Recall Of 27,923 Pemetrexed Injection Vials In Us On July 29, 2026